Status:
COMPLETED
Pain Assessment During Less-Invasive-Surfactant-Administration
Lead Sponsor:
University of Zurich
Conditions:
Infant, Premature, Diseases
Respiratory Distress Syndrome
Eligibility:
All Genders
Up to 48 years
Brief Summary
Primary aims of the study are to evaluate the feasibility of Skin conductance (SC) measurements and its correlation to Neonatal Pain and Distress Scale (N-PASS) - scores during the Less-Invasive-Surfa...
Eligibility Criteria
Inclusion
- Preterm infants ≥27 0/7 weeks of gestation at birth
- Need for surfactant therapy via LISA according to the local standard operating procedure
- ≥27 0/7 weeks of gestation,
- within first 48 hours of life
- FiO2 ≥0.30 to maintain SpO2 ≥90% for 15 min,
- non-invasive respiratory support with PEEP 6-8 cmH2O
- consent of attending NICU staff for videorecording
Exclusion
- Primary intubation in the delivery room
- Severe congenital malformation or other conditions requiring immediate endotracheal intubation
- Insufficient language skills (German or English) of the parents to understand and consent the participation in the study.
Key Trial Info
Start Date :
December 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 17 2024
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06150586
Start Date
December 5 2023
End Date
June 17 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, CH-8091